In-silico DESIGN SCREENING OF SOME PYRAZOLONE FUSED HETEROCYCLIC ANALOGUES AS HER2 INHIBITORS TARGETING BREAST CANCER
This work is licensed under a Creative Commons Attribution 4.0 International License.
Readers around the world
